Original article Open access | J. Bio. Exp. Pharm. 2024, 2(2), 01-16. | https://doi.org/10.62624/JBEP00.0015
Evaluation of phytochemical and pharmacological properties of seeds of Nephelium lappaceum L.
Farhana Alam Ripa, Farzana Tabassum, Raushanara Akter

Abstract

This study aimed to evaluate the antioxidant, analgesic,neuropharmacological, antihyperglycemic, anti-inflammatory, andantidiarrheal properties of the methanolic extract of Nephelium lappaceumL. seeds (MSNL). In vitro antioxidant was determined using the DPPH freeradical scavenging test. Analgesic, antihyperglycemic, antidiarrheal, andanti-inflammatory activities were evaluated using the acetic acid-inducedwrithing test, oral glucose tolerance test, castor oil-induced diarrhea, andcarrageenan-induced paw edema, respectively, using rodents.Neuropharmacological activity was investigated in mice using bothopen-field and hole-cross methods. MSNL demonstrated strong DPPHscavenging capacity (IC50 = 53.92 μg/mL) compared to standard ascorbicacid (IC50 = 41.10 μg/mL). In the acetic acid-induced writhing test, thehighest dose (600 mg/kg) showed 59.89% inhibition of abdominalconstrictions compared to indomethacin (81.97%). MSNL showed asignificant (P<0.05, P<0.01) diminution in the locomotion of rodents in bothopen field, and hole cross methods at the highest dose compared to the controlgroup. MSNL significantly reduced blood glucose levels in mice (P<0.01,P<0.05) in a dose-dependent manner. The highest dose 600 mg/kg of MSNLshowed a significant 53.46% reduction in diarrhea. MSNL 600 mg/kgdisplayed significant inhibition of inflammation at the 3rd hour (65.22%).The findings demonstrated that the extract has potential bioactivities and canbe considered as the benchmark for the isolation of pure bioactivecompounds from this plant to discover new drugs.